NVMDF

Novamind Inc.

Calendar116 views7 min read

Novamind Files Management Information Circular for Special Meeting of Shareholders and Announces Receipt of Interim Court Order for Plan of Arrangement

Novamind
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.Shareholders are encouraged to vote their common shares prior to the proxy deadline of June 6, 2022 at 2:00 p.m. ETTORONTO, ON / ACCESSWIRE / May 11, 2022 ... Read More...
993 views4 min read

Novamind Expands Group Therapy Model

Novamind
Innovative in-person and virtual group offerings increase access to care and social connectionTORONTO, ON / ACCESSWIRE / March 24, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, announced today that it is launching Groups by Novamind, an expansion of t... Read More...
48 views2 min read

Novamind Grants Restricted Share Units

Novamind
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.TORONTO, ON / ACCESSWIRE / March 11, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psych... Read More...
123 views3 min read

Novamind Publishes Psychedelic Therapy Patient Case Studies

Novamind
TORONTO, ON / ACCESSWIRE / February 22, 2022 / Novamind Inc.(CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, today launched Healing Stories, a series of case studies with first-hand accounts of patient experiences with psychedelic-assisted psychotherapy at Novamind clinics (... Read More...
119 views3 min read

Novamind Appoints Prakash Gowd as Chief Operating Officer

Novamind
TORONTO, ON / ACCESSWIRE / February 8, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that Prakash Gowd has been appointed as the Company's Chief Operating Officer (COO), replacing Pierre Bou-Mansour who is leaving the Company th... Read More...
M & A706 views4 min read

Novamind Closes Arizona Acquisition

Novamind
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.TORONTO, ON / ACCESSWIRE / January 18, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psy... Read More...
Joint Venture121 views4 min read

Novamind Partners with Uruguay-Based Bienstar Wellness to Develop Latin America’s First Integrative Mental Health Clinic Network

Novamind
Strategic investment and advisory agreement enables the global expansion of Novamind's psychedelic clinic modelTORONTO, ON / ACCESSWIRE / December 1, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, today announced a strategic investment and advisory agr... Read More...
Financials1353 views2 min read

Novamind Announces Cease Trade Order and Delay in Filing Annual Financial Statements

Novamind
TORONTO, ON / ACCESSWIRE / November 4, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, today announced that it is the subject of a failure-to-file cease trade order issued by the Ontario Securities Commission on November 3, 2021 as a result of the Compa... Read More...
1232 views3 min read

Novamind Unveils Stealth Mode Investment in Alto Neuroscience

Novamind
TORONTO, ON / ACCESSWIRE / October 22, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, is pleased to unveil Alto Neuroscience ("Alto"), a clinical-stage biopharmaceutical company, as its previously announced stealth mode investment. In June 2021, Novami... Read More...
496 views3 min read

Novamind Launches New Psychedelic Palliative Care Program

Novamind
Specialized program to research and scale access to psychedelic medicine opens new doors for patients with chronic and serious illnessTORONTO, ON / ACCESSWIRE / October 7, 2021 /Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, is pleased to launch Psychedelic P... Read More...
1491 views3 min read

Novamind Opens 5th Clinic Location Specialized in Integrative Psychiatry for Patients with Treatment-Resistant Conditions

Novamind
Company executes organic growth mandate, on track to open four new clinics by Q3 2021TORONTO, ON / ACCESSWIRE / July 29, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has completed the construction of a new clinic foc... Read More...





Make smarter investment strategies
with in-depth news reports

Join our subscribers!